Last reviewed · How we verify
Recombinant Human Interferon a-2b Gel — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Recombinant Human Interferon a-2b Gel (Recombinant Human Interferon a-2b Gel) — Lee's Pharmaceutical Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Recombinant Human Interferon a-2b Gel TARGET | Recombinant Human Interferon a-2b Gel | Lee's Pharmaceutical Limited | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Recombinant Human Interferon a-2b Gel CI watch — RSS
- Recombinant Human Interferon a-2b Gel CI watch — Atom
- Recombinant Human Interferon a-2b Gel CI watch — JSON
- Recombinant Human Interferon a-2b Gel alone — RSS
Cite this brief
Drug Landscape (2026). Recombinant Human Interferon a-2b Gel — Competitive Intelligence Brief. https://druglandscape.com/ci/recombinant-human-interferon-a-2b-gel. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab